Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine
PC Chen, MH Tsai, SKH Yip, YC Jou, CF Ng… - BMC medical …, 2011 - Springer
Background Bladder cancer is the sixth most common cancer in the world and the incidence
is particularly high in southwestern Taiwan. Previous studies have identified several tumor …
is particularly high in southwestern Taiwan. Previous studies have identified several tumor …
[PDF][PDF] Epigenetics application in the diagnosis and treatment of bladder cancer
A Harb-De la Rosa, M Acker, RA Kumar, M Manoharan - Can J Urol, 2015 - canjurol.com
Results: The most important epigenetic changes include DNA methylation, histone
modification and microRNA regulation. Both DNA hypomethylation and hypermethylation …
modification and microRNA regulation. Both DNA hypomethylation and hypermethylation …
A bird eye view on cystic fibrosis: An underestimated multifaceted chronic disorder
Cystic fibrosis (CF) is an autosomal recessive disease which involves the mutations in the
cystic fibrosis transmembrane conductance regulator (CFTR) gene. CF involves in the …
cystic fibrosis transmembrane conductance regulator (CFTR) gene. CF involves in the …
Hypermethylation of TWIST1 and NID2 in Tumor Tissues and Voided Urine in Urinary Bladder Cancer Patients
Bladder cancer like other cancers arises from the accumulation of many genetic and
epigenetic changes that lead to the activation of proto-oncogenes or inactivation of tumor …
epigenetic changes that lead to the activation of proto-oncogenes or inactivation of tumor …
Quantitative methylation analysis of BCL2, hTERT, and DAPK promoters in urine sediment for the detection of non-muscle-invasive urothelial carcinoma of the bladder …
S Vinci, G Giannarini, C Selli, J Kuncova… - … Oncology: Seminars and …, 2011 - Elsevier
OBJECTIVES: Urinary hypermethylation of BCL2, hTERT, and DAPK promoters has been
previously demonstrated as an accurate biomarker for the detection of urothelial carcinoma …
previously demonstrated as an accurate biomarker for the detection of urothelial carcinoma …
Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 Are Promising Markers for the Detection of Colorectal Cancer in Blood
V Melotte, JM Yi, MHFM Lentjes, KM Smits… - Cancer prevention …, 2015 - AACR
Identifying biomarkers in body fluids may improve the noninvasive detection of colorectal
cancer. Previously, we identified N-Myc downstream-regulated gene 4 (NDRG4) and GATA …
cancer. Previously, we identified N-Myc downstream-regulated gene 4 (NDRG4) and GATA …
[HTML][HTML] Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?
Urothelial bladder cancer is a complex disease displaying a landscape of heterogenous
molecular subtypes, mutation profiles and clinical presentations. Diagnosis and surveillance …
molecular subtypes, mutation profiles and clinical presentations. Diagnosis and surveillance …
Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk
Y Li, Z Sun, Y Wu, D Babovic-Vuksanovic, Y Li… - Lung cancer, 2010 - Elsevier
The cystic fibrosis transmembrane conductance regulator (CFTR) holds an important role in
retaining lung function, but its association with lung cancer is unclear. A case-control study …
retaining lung function, but its association with lung cancer is unclear. A case-control study …
Hypermethylation reduces expression of tumor‐suppressor PLZF and regulates proliferation and apoptosis in non‐small‐cell lung cancers
X Wang, L Wang, S Guo, Y Bao, Y Ma, F Yan… - The FASEB …, 2013 - Wiley Online Library
Deregulation of promyelocytic leukemia zinc finger protein (PLZF), a tumor suppressor gene,
was reported in different types of solid tumors. This study for the first time explored the …
was reported in different types of solid tumors. This study for the first time explored the …
Urinary levels of Bcl-2 are elevated in ovarian cancer patients
NS Anderson, Y Bermudez, D Badgwell, R Chen… - Gynecologic …, 2009 - Elsevier
OBJECTIVE (S): The poor prognosis associated with ovarian cancer is due to the lack of
overt early symptoms and the absence of reliable diagnostic screening methods. Since …
overt early symptoms and the absence of reliable diagnostic screening methods. Since …